| Cash Flow | 2025-07-31 |
|---|---|
| Net (loss) income | 188,366 |
| Depreciation and amortization | 72,701 |
| Stock-based compensation | 351,590 |
| Amortization of debt discount and issuance cost | 3,877 |
| Conversion of convertible senior notes attributable to debt discount and issuance costs | 0 |
| Operating lease cost, net of accretion | 29,029 |
| Early exit of lease-related assets | 0 |
| Gain on frame divestiture | 0 |
| Non-cash interest expense | 0 |
| Inducement expense from partial repurchase of the 2027 notes | 11,347 |
| Other | 4,829 |
| Accounts receivable, net | 71,886 |
| Deferred commissions | -16,517 |
| Prepaid expenses and other assets | 8,101 |
| Accounts payable | 30,018 |
| Accrued compensation and benefits | 33,286 |
| Accrued expenses and other liabilities | -4,269 |
| Operating leases, net | -29,954 |
| Deferred revenue | 203,764 |
| Net cash provided by operating activities | 821,456 |
| Maturities of investments | 476,173 |
| Purchases of investments | 1,359,593 |
| Sales of investments | 3,016 |
| Proceeds from frame divestiture | 0 |
| Payments for acquisitions, net of cash acquired | 0 |
| Purchases of property and equipment | 71,283 |
| Net cash (used in) provided by investing activities | -951,687 |
| Repayment of convertible notes | 0 |
| Proceeds from sales of shares through employee equity incentive plans | 68,935 |
| Taxes paid related to net share settlement of equity awards | 256,636 |
| Proceeds from the issuance of convertible notes, net of issuance costs | 848,010 |
| Payment of third-party debt issuance costs | 3,448 |
| Partial repurchase of the 2027 notes | 95,453 |
| Payment of revolver issuance costs | 2,794 |
| Repurchases of common stock | 307,900 |
| Payment of finance lease obligations | 4,628 |
| Deferred payment of purchases of property and equipment | 2,000 |
| Net cash (used in) provided by financing activities | 244,086 |
| Net increase in cash, cash equivalents and restricted cash | 113,855 |
| Cash and cash equivalents at beginning of period | 655,662 |
| Cash and cash equivalents at end of period | 769,517 |
Nutanix, Inc. (NTNX)
Nutanix, Inc. (NTNX)